カルレティキュリン
関連文献

“The evolutionary history of calreticulin and calnexin genes in green plants”. Genetica 139 (2):  225–9. (Feb 2011). doi:10.1007/s10709-010-9544-y. PMID 21222018.
“Calreticulin”. The International Journal of Biochemistry & Cell Biology 30 (5):  553–8. (May 1998). doi:10.1016/S1357-2725(97)00153-2. PMID 9693955.
“Congenital heart block not associated with anti-Ro/La antibodies: comparison with anti-Ro/La-positive cases”. The Journal of Rheumatology 36 (8):  1744–8. (Aug 2009). doi:10.3899/jrheum.080737. PMC 2798588. PMID 19567621. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798588/.
“Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer”. World Journal of Gastroenterology 16 (19):  2428–34. (May 2010). doi:10.3748/wjg.v16.i19.2428. PMC 2874150. PMID 20480531. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874150/.
“A mechanism of release of calreticulin from cells during apoptosis”. Journal of Molecular Biology 401 (5):  799–812. (Sep 2010). doi:10.1016/j.jmb.2010.06.064. hdl:10871/20264. PMID 20624402.
“Calreticulin enhances B2 bradykinin receptor maturation and heterodimerization”. Biochemical and Biophysical Research Communications 387 (1):  186–90. (Sep 2009). doi:10.1016/j.bbrc.2009.07.011. PMID 19580784. https://www.zora.uzh.ch/id/eprint/25081/1/Accepted-manuscript-BBRC-387-186-2009.pdf.
“Getting in and out from calnexin/calreticulin cycles”. The Journal of Biological Chemistry 283 (16):  10221–5. (Apr 2008). doi:10.1074/jbc.R700048200. PMC 2447651. PMID 18303019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2447651/.
“Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma”. Oncogene 28 (42):  3714–22. (Oct 2009). doi:10.1038/onc.2009.237. PMID 19684620.
“Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum”. The International Journal of Biochemistry & Cell Biology 37 (2):  260–6. (Feb 2005). doi:10.1016/j.biocel.2004.02.030. PMID 15474971.
“Transcriptional control of the calreticulin gene in health and disease”. The International Journal of Biochemistry & Cell Biology 41 (3):  531–8. (Mar 2009). doi:10.1016/j.biocel.2008.06.020. PMID 18765291.
“Calreticulin controls the rate of assembly of CD1d molecules in the endoplasmic reticulum”. The Journal of Biological Chemistry 285 (49):  38283–92. (Dec 2010). doi:10.1074/jbc.M110.170530. PMC 2992262. PMID 20861015. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992262/.
“Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip”. American Journal of Human Genetics 85 (5):  628–42. (Nov 2009). doi:10.1016/j.ajhg.2009.10.014. PMC 2775832. PMID 19913121. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775832/.
“Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention”. Journal of Immunology 186 (1):  62–72. (Jan 2011). doi:10.4049/jimmunol.0903657. PMC 3129036. PMID 21115737. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129036/.
“Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells”. Arthritis and Rheumatism 62 (10):  2919–29. (Oct 2010). doi:10.1002/art.27602. hdl:10871/13850. PMID 20533543. https://ore.exeter.ac.uk/repository/bitstream/10871/13850/2/AandR%202010.pdf.
“Lysyl tRNA synthetase is required for the translocation of calreticulin to the cell surface in immunogenic death”. Cell Cycle 9 (15):  3072–7. (Aug 2010). doi:10.4161/cc.9.15.12459. PMID 20699648.
“Altered expression of glycoproteins on the cell surface of Jurkat cells during etoposide-induced apoptosis: shedding and intracellular translocation of glycoproteins”. Biochimica et Biophysica Acta (BBA) - General Subjects 1790 (10):  1198–205. (Oct 2009). doi:10.1016/j.bbagen.2009.05.019. PMID 19524015.
“Functional analysis of recombinant calreticulin fragment 39-272: implications for immunobiological activities of calreticulin in health and disease”. Journal of Immunology 185 (8):  4561–9. (Oct 2010). doi:10.4049/jimmunol.1000536. PMID 20855873.
“Suppressive roles of calreticulin in prostate cancer growth and metastasis”. The American Journal of Pathology 175 (2):  882–90. (Aug 2009). doi:10.2353/ajpath.2009.080417. PMC 2716982. PMID 19608864. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716982/.
“Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study”. Diabetes Care 33 (10):  2250–3. (Oct 2010). doi:10.2337/dc10-0452. PMC 2945168. PMID 20628086. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945168/.
“Novel mutations in the calreticulin gene core promoter and coding sequence in schizoaffective disorder”. American Journal of Medical Genetics Part B 153B (2):  706–9. (Mar 2010). doi:10.1002/ajmg.b.31036. PMID 19760677.
“Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia”. Journal of Cellular and Molecular Medicine 14 (6B):  1509–19. (Jun 2010). doi:10.1111/j.1582-4934.2009.00870.x. PMC 3829017. PMID 19659458. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829017/.